Inscription Capital LLC Sells 957 Shares of The Procter & Gamble Company (NYSE:PG)

Inscription Capital LLC decreased its position in The Procter & Gamble Company (NYSE:PG) by 1.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,075 shares of the company’s stock after selling 957 shares during the period. Procter & Gamble makes up about 1.6% of Inscription Capital LLC’s portfolio, making the stock its 15th biggest holding. Inscription Capital LLC’s holdings in Procter & Gamble were worth $10,578,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. raised its stake in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at about $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at about $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of a number of analyst reports. Evercore ISI upped their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Price Performance

Shares of PG stock traded up $0.74 during trading hours on Monday, reaching $168.96. The company had a trading volume of 459,697 shares, compared to its average volume of 6,639,543. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a market capitalization of $398.77 billion, a price-to-earnings ratio of 27.49, a PEG ratio of 3.67 and a beta of 0.41. The stock has a fifty day moving average of $171.93 and a 200-day moving average of $167.69. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the prior year, the firm posted $1.83 earnings per share. The firm’s quarterly revenue was down .6% on a year-over-year basis. On average, equities analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 397,986 shares of company stock worth $67,642,430. Insiders own 0.17% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.